Michael Reubold talked to Evonik’s Sanjeev Taneja about the role of catalysts in the company and their value to the industry and the society.

The European Chemical Industry has set out on an ambitious path to become carbon neutral.

Evonik has entered into an agreement to buy the Lactel absorbable polymer business from Durect Corp., a US-based biopharmaceutical company focused on developing drugs for...

German specialty chemicals producer Evonik says it is on track to complete the ongoing €400 million expansion of its PA 12 portfolio as planned, despite a few logistical...

Evonik and Siemens Energy have commissioned a pilot plant that uses carbon dioxide (CO2) and water to produce chemicals. The plant is the culmination of two years’ work...

The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...

Specialty chemicals producer Evonik is investing around €15 million in its C4 production network in Marl. Germany. The three-pronged focus is on Tert. butanol (TBA), di...

In a move designed to boost its catalyst business, Evonik will pay $210 million to acquire the Porocel Group, a US technology provider based in Houston, Texas. The...